BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6797874)

  • 1. [Present status of cytological screening for cervix neoplasms].
    Naujoks H
    Gynakologe; 1981 Dec; 14(4):204-11. PubMed ID: 6797874
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cervix cancer screening: results of a french team].
    Salvat J; Slamani L; Schmidt MH
    Rev Med Suisse Romande; 1997 Aug; 117(8):593-6. PubMed ID: 9340713
    [No Abstract]   [Full Text] [Related]  

  • 3. [Costs and problems in cervix cancer screening are considerably underestimated].
    Bistoletti P
    Lakartidningen; 2000 Aug; 97(32-33):3506-8. PubMed ID: 11037597
    [No Abstract]   [Full Text] [Related]  

  • 4. Cervical cancer screening data from two cohorts in British Columbia.
    van Oortmarssen GJ; Habbema JD
    IARC Sci Publ; 1986; (76):47-60. PubMed ID: 3570415
    [No Abstract]   [Full Text] [Related]  

  • 5. [A reply on cervix cancer screening: cervical cytological test doesn't fulfil the requirements of a good screening test].
    Bistoletti P
    Lakartidningen; 2000 Sep; 97(37):4042. PubMed ID: 11036367
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cost-benefit of expanding cervical cancer screening].
    Deng J; Tan H; Yang T; Huang X; Zhou S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 May; 35(5):470-5. PubMed ID: 20543471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is cervical screening justified in adolescents?].
    Barrasso R; Monsonego J
    Contracept Fertil Sex; 1996 Feb; 24(2):101-3. PubMed ID: 8611929
    [No Abstract]   [Full Text] [Related]  

  • 8. Improving the sensitivity of cervical cytology: what are the issues?
    Myers ER
    Am J Manag Care; 2000 Jul; 6(7):838-40. PubMed ID: 11067380
    [No Abstract]   [Full Text] [Related]  

  • 9. [Critique of cytology as a mass-screening method].
    Pflanz M
    Fortschr Med; 1974 Mar; 92(9):351-2 passim. PubMed ID: 4819501
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cervix cancer screening can be cost-effective. Combination of vaginal smears and the HPV test should be even more beneficial].
    Bistoletti P; Ellström A; Dillner J; Sennfält K; Sparén P; Strander B
    Lakartidningen; 2005 Jun 13-26; 102(24-25):1874-6, 1878-9. PubMed ID: 16044766
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytological diagnosis and invasive cervix cancer].
    Gårdmark S; Johnsson JE; Sjöberg NO; Stormby N
    Lakartidningen; 1979 Jan; 76(5):279-80. PubMed ID: 759773
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy of organized screening in comparison to spontaneous Pap samples in the prevention of invasive cervical cancer].
    Kallio M; Nieminen P; Anttila A; Hakama M
    Duodecim; 2001; 117(14):1442-6. PubMed ID: 12181953
    [No Abstract]   [Full Text] [Related]  

  • 13. Economics of screening for cancer of the cervix.
    Hicks S; Edwards D
    N Z Med J; 1986 Nov; 99(814):916. PubMed ID: 3468422
    [No Abstract]   [Full Text] [Related]  

  • 14. [Editorial: Vaginal-cytological screening for cervix cancer].
    Ostergaard E
    Ugeskr Laeger; 1976 Apr; 138(17):1043-4. PubMed ID: 1265893
    [No Abstract]   [Full Text] [Related]  

  • 15. [Epidemiology of cancer of the cervix uteri (author's transl)].
    Sachs H; Hasche C
    Geburtshilfe Frauenheilkd; 1974 Nov; 34(11):921-30. PubMed ID: 4435345
    [No Abstract]   [Full Text] [Related]  

  • 16. Economics of screening for cervical cancer.
    Coldman AJ; Anderson GH
    N Z Med J; 1987 Jul; 100(827):425. PubMed ID: 3452069
    [No Abstract]   [Full Text] [Related]  

  • 17. A cohort study of cervical cancer screening in British Columbia.
    Boyes DA; Morrison B; Knox EG; Draper GJ; Miller AB
    Clin Invest Med; 1982; 5(1):1-29. PubMed ID: 7116711
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cytological screening of precancer and cancer of the cervix uteri].
    Novik VI
    Vopr Onkol; 1990; 36(12):1411-8. PubMed ID: 2288117
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of cervical cytology.
    McCrory DC; Matchar DB; Bastian L; Datta S; Hasselblad V; Hickey J; Myers E; Nanda K
    Evid Rep Technol Assess (Summ); 1999 Jan; (5):1-6. PubMed ID: 11925972
    [No Abstract]   [Full Text] [Related]  

  • 20. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
    Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
    Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.